Nonventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality, and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019). Overall NVHAP incidence was 2.63 per 1,000 patient days, and mortality was 7.76%, with an excess cost per NVHAP case of $20,189.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajic.2022.06.016 | DOI Listing |
Publication Analysis
Top Keywords
incidence mortality
8
nonventilator hospital-acquired
8
hospital-acquired pneumonia
8
medicaid beneficiaries
8
mortality costs
8
nvhap incidence
8
mortality cost
4
cost trends
4
trends nonventilator
4
pneumonia medicaid
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!